Frontiers in Endocrinology (Dec 2024)

Response: Commentary: Azathioprine as an adjuvant therapy in severe Graves’ disease: a randomized controlled open-label clinical trial

  • Magdy Mohamed Allam,
  • Ramy Mohamed Ghazy,
  • Ramy Mohamed Ghazy,
  • Hanaa Tarek Hussein Elzawawy

DOI
https://doi.org/10.3389/fendo.2024.1473224
Journal volume & issue
Vol. 15

Abstract

Read online

No abstracts available.

Keywords